Lung cancer study aims to decode immune secrets from tiny biopsies

NCT ID NCT07150598

First seen Sep 30, 2025 · Last updated May 16, 2026 · Updated 30 times

Summary

This study looks at how the immune system and certain genes affect treatment in people with advanced non-small cell lung cancer. Researchers will collect small tumor samples before and during treatment to study immune markers. The goal is to learn more about why some patients respond better to immunochemotherapy. This study does not test any new drug or treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NSCLC (NON-SMALL CELL LUNG CANCER) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Universitätsklinikum Carl Gustav Carus

    Dresden, Saxony, 01307, Germany

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Universitätsklinikum Köln, Centrum für Integrierte Onkologie (CIO) Köln

    Cologne, North Rhine-Westphalia, 50937, Germany

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.